SGTs

Freq.

M: F

Age range (yrs)

Mean age (yrs) (±SD)

Percentage of total tumours

Percentage in group (benign or malignant)

BENIGN

Pleomorphic adenoma

27

1.1:1

15 - 75

36.30 (±16.84}

26.2

77.1

Haemangioma

3

2:1

13 - 25

17.00 (±6.93)

2.9

8.6

Monomorphic adenoma

2

0:2

25 - 38

30.50 (±10.61)

1.9

5.7

Neurofibroma

2

0:2

20 - 22

21.00 (±1.41)

1.9

5.7

Lymphangioma

1

0:1

1

0.90

1.0

2.9

Total benign

35

1:1.2

1 - 75

32.43 (±17.12)

34.0

100

MALIGNANT

Squamous cell carcinoma

32

1.3:1

20 - 71

49.38 (±16.01)

31.1

47.1

Adenoid cystic carcinoma

16

1.3:1

23 - 75

49.19 (±15.68)

15.5

23.5

Mucoepidermoid carcinoma

6

1:1

13 - 53

30.83 (±16.73)

5.8

8.8

Sarcoma

5

1.5:1

25 - 45

33.20 (±8.87)

4.9

7.4

Lymphoma

3

2:1

35 - 58

47.67 (±11.68)

2.9

4.4

Carcinoma ex-pleomorphic adenoma

2

2:0

55 - 60

57.50 (±3.54)

1.9

2.9

Acinic cell carcinoma

1

0:1

51

51.00

1.0

1.5

Adenocarcinoma

1

0:1

24

24.00

1.0

1.5

Salivary ductal carcinoma

1

1:0

35

35.00

1.0

1.5

Basal cell adenocarcinoma

1

1:0

70

70.00

1.0

1.5

Total malignant

68

1.4:1

13 - 75

46.41 (±16.31)

66.0

100

TOTAL

103

1.2:1

1 - 75

41.66 (±17.80)

100.0